13F-HR filed by CVS HEALTH Corp
CVS HEALTH Corp filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-10, with 6 holding rows worth $115,994,820.
- Accession
- 0000947871-23-000152
- Filer
- CIK 64803
- Filed
- 2023-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 6 entries on the cover page, a total value of $115,994,820 stated on the cover page (in dollars after the unit check, H1), rows summing to $115,994,820 with VALUE read as dollars as filed, 13F file number 028-22498. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ISHARES TR | 46429B663 | CORE HIGH DV ETF | 624,536 | $65,101,633 | dollars as filed | |
| Vanguard High Dividend Yield ETF | 921946406 | SHS | 212,832 | $23,030,551 | dollars as filed | |
| SCHD | 808524797 | COM | 297,006 | $22,435,833 | dollars as filed | |
| LUMIRADX LTD | g5709l117 | WT | 5,352,106 | $4,816,895 | dollars as filed | |
| HEALTH CATALYST INC | 42225T107 | COM | 32,273 | $343,057 | dollars as filed | |
| PRUDENTIAL FINL INC COM | 744320102 | Stock | 2,683 | $266,851 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000947871-23-000152 | this filing | 2023-02-10 | acceptance time not in the bulk data set |